The company said it will use the net proceeds to redeem the outstanding $500 million aggregate principal amount of senior notes maturing in January 2018.
The ratings agency also assigned a Negative Rating Watch to the firm's notes offering, noting it will resolve this notation as more details of the offering become available.
The firm plans to use the funds to repay outstanding debts and for general corporate purposes.
The firm has not disclosed the amount it is seeking, but said it plans to use the funds to repay outstanding debts and for general corporate purposes.
The company said it will use most of the proceeds to redeem the outstanding $900 million principal amount of its 1.30 percent senior notes due 2017.
Fitch has given the two-year senior notes offering a BBB rating with a Stable outlook.
The 10-year notes were rated BBB by Fitch, which also declared the ratings outlook Stable.
The firm sold three series of senior notes and will use proceeds to repay other outstanding debt.
The firm will use the proceeds along with cash on hand to redeem notes that mature in August.
The Salt Lake City-based company said it would use the $18.4 million in expected gross aggregate proceeds for product pipeline development and customer growth.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.